Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 18 of 18 for “"Pantoprazole"”.
-
Investigations of pantoprazole in healthy neonatal ruminants
… explores the use of the proton pump inhibitor pantoprazole as a potential for the treatment of ulceration in ruminants modeled by neonatal calves. Pharmacokinetic and pharmacodynamic studies were performed to evaluate the compound's effect on abomasal pH. In the first pharmacokinetic study, …
-
Deprescribing Unnecessary Pantoprazole Prescribed by Hospitalists on Parkland Hospital Non-ICU Inpatient Floors
… relative reduction in inappropriate inpatient pantoprazole prescribing by the hospital medicine physicians and advanced practice providers who account for the majority of the unnecessary proton pump inhibitor prescribing in non-critical patients at Parkland during the period of January 2018-May …
-
The effect of the proton pump inhibitor pantoprazole on the biology of Campylobacter jejuni
… on the biology ofC. jejuni. Exposure to the PPI pantoprazole was found to affect C. jejuni growth/survival, motility, morphology, biofilm formation, invasion potential and susceptibility to some conventional antibiotics. Microarray studies showed that the cmeA and Cj0561c genes were significantly …
-
Autophagy as a Survival Mechanism for Tumor Cells Exposed to Chemotherapy or Hypoxia, and its Inhibition by Pantoprazole to Improve Outcome of Treatment
… The clinically used proton pump inhibitor (PPI) pantoprazole inhibits proton pumps, and is reported to inhibit autophagy. This thesis aims to gain insight as to whether pantoprazole inhibits autophagy to improve penetration and activity of anticancer drugs in solid tumors, thereby enhancing …
-
THE ROLE OF ABCG2 IN DRUG ACTIVE TRANSPORT IN MILK
… interaction between ABCG2/Abcg2 and pantoprazole on drug transport in milk, (3) to understand in vitro monolayer flux model using experimental data and a mechanistic mathematical model. Quantitive PCR, Western blotting and immunohistochemistry results indicated that Abcg2 was …
-
IMPDH- und MPA-Messungen zur Klärung der Interaktionen zwischen Mycophenolat-Natrium und dem Protonenpumpeninhibitor Pantoprazol nach primärer orthotoper Herztransplantation
… the impact of the proton pump inhibitor (PPI) pantoprazole on the bioavailability of mycophenolic acid (MPA) after oral administration of enteric-coated mycophenolate sodium (EC-MPS; Myfortic) in heart or lung transplant recipients. Previously we demonstrated that pantoprazole reduces the MPA …
-
Distribution of Anti-cancer Drugs within Solid Tumours and Normal Tissues and its Potential for Modification to Improve Therapeutic Index
… extracellular drug distribution was determined. Pantoprazole increased endosomal pH in cells, leading to less sequestration of doxorubicin within them, and increased the toxicity of doxorubicin for cultured cells. In wild-type MCF7 tumours, pretreatment with pantoprazole enhanced doxorubicin …
-
Análise clínica e econômica da conversão do pantoprazol intravenoso para oral em pacientes críticos
… in critically ill patients receiving intravenous pantoprazole, including physician acceptance and the effects on duration of use by route of administration, length of hospital stays and mortality. Method: A quasi-experimental cost-minimization study conducted in a private ICU from 2019 to 2023, …
-
Using Statistical Techniques and Machine Learning to Assess Potential Biomarkers and Clinical Characteristics for Differences between Chronic Hepatitis C Virus and Hepatocellular Carcinoma
… identified N-methyl Proline, Octadecanedioate, Pantoprazole, and Xylitol. Logistic Regression identified 3-hydroxypropanoate, Laurylcarnitine, N4-acetylcytidine, N6-acetyllysine, Octadecanedioate, Oleoylcarnitine, Pantoprazole, and Xylitol.
-
AN IN VITRO INVESTIGATION INTO THE MECHANISM OF THE CLINICALLY RELEVANT DRUG-DRUG INTERACTION BETWEEN OMEPRAZOLE OR ESOMEPRAZOLE AND CLOPIDOGREL
… omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole) with clopidogrel to decrease the risk of upper gastrointestinal bleeding. This practice was formalized for high risk patients by the American Heart Association (and others) in 2008. By 2009, numerous publications …
-
Acid Reflux Medications are Associated with Reduced Periodontal Disease Severity (NHANES 2011-2012 and 2013-2014)
… pump inhibitors (PPIs), such as omeprazole and pantoprazole, are frequently used to treat gastrointestinal (GI) disorders, such as gastroesophageal reflux disease. PPIs inhibit the H+/K+-ATPase pump in gastric parietal cells and block gastric acid secretion. PPIs also can affect calcium …
-
Διερεύνηση των μηχανισμών του κυτταρικού stress κατόπιν επιδράσεως χημειοθεραπευτικών παραγόντων ρυθμιστών των αντιδράσεων υπερευαισθησίας και φαρμάκων του γαστρεντερικού
… incubation with cycloheximide, omeprazole, pantoprazole, amiodarone, dronedarone, C48/80, cromolyn, geldanamycin, 17-allylamine-17-dimethoxy-geldanamycin, irinotecan, suramin and doxorubicin, pointed to the involvement of de novo protein synthesis, + and Ca2+ homeostasis, hsp90 and …
-
Potential Effects of Proton Pump Inhibitors on Periodontal Disease: A Systematic Review
… FDA-approved PPIs (rabeprazole, lansoprazole, pantoprazole, omeprazole, dexlansoprazole, esomeprazole) were included. Risk of bias was performed using the OHAT and QUIN assessment tools. Results: A total of 260 studies were included. Primary effects of PPIs involved alterations in bone, …
-
Untersuchung des Effekts der Langzeiteinnahme von Protonenpumpenhemmern auf das Risiko für Herzinfarkt und Schlaganfall
… investigated the effect of continuous intake of pantoprazole on the risk of a broad spectrum of outcomes over a period of three years. In a study population with a significant proportion of prevalent cardiovascular disease there was no indication for an increased risk of cardiovascular events or …
-
The Relationship Between Proton Pump Inhibitors and Periodontitis
… pump inhibitors (PPIs), such as omeprazole and pantoprazole, are frequently prescribed for the treatment of acid-related gastrointestinal (GI) diseases. PPIs inhibit the H+-K+-ATPase proton pump in gastric parietal cells, which decreases acid release. However, PPIs also affect bone metabolism by …
-
Novel mechanism of gastric proton pump inhibitor (PPI) : Suppression of Helicobacter-pylori induced angiogenesis and selective induction of apoptosis in gastric cancer cells.
… to induce the cell death, we hypothesized that pantoprazole (PPZ), one of gastric H+/K+-ATPase inhibitors used frequently to treat acid-related diseases, could inhibit growth of tumor cells. And, although activation of mitogen activated protein kinases (MAPKs) by Helicobacter pylori infection is …
-
Micropartículas contendo pantoprazol sódico: desenvolvimento tecnológico, produção em escala piloto e avaliação biológica
Micropartículas contendo pantoprazol foram preparadas e caracterizadas a fim de se obter sistemas multiparticulados gastro-resistentes. O trabalho foi delineado buscando-se a melhor técnica de preparação das micropartículas, assim como o estudo do processo, aumento de escala e avaliação biológica. …